Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Proleukin cleared for marketing in U.S. for melanoma indication

Jan. 30, 1998

No Comments

AltaRex reacquires Western European marketing rights to Ovarex

Jan. 27, 1998

No Comments

New approach to cancer therapy reported

Jan. 27, 1998

No Comments

Vical receives patent protection for lipid-mediated DNA vaccines

Jan. 8, 1998

No Comments

Mechanism of TNF-alpha production in tumor tissues by Ono-4007

Jan. 5, 1998

No Comments

Favorable phase III trial results reported for HER2 monoclonal antibody

Dec. 31, 1997

No Comments

Chiron's Proleukin recommended for approval for new indication

Dec. 23, 1997

No Comments

New antitumor agent in development in China

Dec. 22, 1997

No Comments

Idec's immunotherapy shows promise in phase I/II for non-Hodgkin's lymphoma

Dec. 22, 1997

No Comments

MAb for non-Hodgkin's lymphoma now available in U.S.

Dec. 19, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Immuno-oncology
RSS

Proleukin cleared for marketing in U.S. for melanoma indication

AltaRex reacquires Western European marketing rights to Ovarex

New approach to cancer therapy reported

Vical receives patent protection for lipid-mediated DNA vaccines

Mechanism of TNF-alpha production in tumor tissues by Ono-4007

Favorable phase III trial results reported for HER2 monoclonal antibody

Chiron's Proleukin recommended for approval for new indication

New antitumor agent in development in China

Idec's immunotherapy shows promise in phase I/II for non-Hodgkin's lymphoma

MAb for non-Hodgkin's lymphoma now available in U.S.

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Cell mapping yields clues to metabolic health in obese individuals

Ionis notches Arrowhead win; Tryngolza cleared for FCS

Immuno-oncology RSS

Immuno-oncology
RSS